Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: Results of a multicenter, baseline-controlled safety and efficacy study in 160 patients
- 30 September 1986
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 112 (3) , 498-505
- https://doi.org/10.1016/0002-8703(86)90513-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmiasAmerican Heart Journal, 1986
- Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: A multicenter double-blind clinical trialAmerican Heart Journal, 1985
- Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metaboliteClinical Pharmacology & Therapeutics, 1983
- Ultra-short acting beta-blockers: A proposal for the treatment of the critically ill patientLife Sciences, 1982
- The electrophysiologic effects of intravenous propranolol in the Wolff-Parkinson-White syndromeAmerican Heart Journal, 1979
- Acebutolol in supraventricular arrhythmiasClinical Pharmacology & Therapeutics, 1979
- Rheological and biochemical changes in open heart surgery with extracorporeal circulation and moderate hypothermiaResuscitation, 1979
- Effects of propranolol on anomalous pathway refractoriness and circus movement tachycardias in patients with preexcitationThe American Journal of Cardiology, 1978
- Reduction of Blood Usage in Open Heart SurgeryChest, 1976
- Effects of Beta-Adrenergic Blockade with Propranolol in Patients with Atrial ArrhythmiasNew England Journal of Medicine, 1965